Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cytomx Therapeutics

Clinical trials sponsored by Cytomx Therapeutics, explained in plain language.

CytomX Therapeutics CTMX NASDAQ

A biotechnology company developing conditionally activated antibody therapeutics for cancer and other diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Terminated 1

Cancer drug combo study halted after just 3 patients

Disease control Terminated

This study tested a new drug called CX-072 combined with other cancer treatments for adults with solid tumors or advanced melanoma. The goal was to see if the combination could shrink tumors. However, the study was stopped early and only 3 people took part, so we don't have enoug…

Phase: PHASE2 • Sponsor: CytomX Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC